Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)

NCT07166666 is registered in ClinicalTrials.gov with Oman Medical Speciality Board as lead sponsor.

NCT NCT07166666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07166666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)
Lead sponsor
Oman Medical Speciality Board
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
October 1, 2026
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia assessment, sedation